FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 5.050
EU - Europa 2.312
AS - Asia 1.524
SA - Sud America 23
OC - Oceania 22
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.949
Nazione #
US - Stati Uniti d'America 4.977
CN - Cina 530
SG - Singapore 518
IT - Italia 495
SE - Svezia 430
DE - Germania 394
IE - Irlanda 268
RU - Federazione Russa 254
HK - Hong Kong 170
GB - Regno Unito 158
VN - Vietnam 103
UA - Ucraina 74
CA - Canada 69
DK - Danimarca 65
ID - Indonesia 49
IN - India 43
FR - Francia 40
TR - Turchia 40
AT - Austria 30
FI - Finlandia 25
JP - Giappone 23
KR - Corea 22
AU - Australia 20
BE - Belgio 20
BR - Brasile 20
NL - Olanda 16
EG - Egitto 9
ES - Italia 9
IR - Iran 7
TW - Taiwan 7
HR - Croazia 6
RO - Romania 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EU - Europa 5
PT - Portogallo 4
BG - Bulgaria 3
RS - Serbia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
GT - Guatemala 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
TH - Thailandia 2
AR - Argentina 1
DZ - Algeria 1
KW - Kuwait 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.949
Città #
Ann Arbor 1.897
Singapore 414
Wilmington 346
Chandler 323
Dublin 260
Frankfurt am Main 253
Dearborn 236
Milan 210
Ashburn 185
Woodbridge 185
Hong Kong 170
Houston 145
New York 140
Fairfield 139
Princeton 134
Santa Clara 122
Nanjing 112
Jacksonville 86
Boardman 76
Seattle 65
Guangzhou 55
Jakarta 45
Shanghai 43
Nanchang 42
Dong Ket 41
Cambridge 37
Lawrence 32
Shenyang 29
Vienna 29
Beijing 28
Altamura 26
Hangzhou 23
Los Angeles 21
Shangdi 21
Jinan 20
Pune 20
Ottawa 19
Zhengzhou 19
Toronto 18
Brussels 17
Kunming 17
Sacramento 16
Andover 15
Fremont 15
Sydney 15
Falls Church 14
Kocaeli 14
Mainz 14
Portland 14
Edmonton 12
San Diego 12
Tianjin 12
Changsha 11
Helsinki 11
Lissone 11
Chicago 10
Dallas 10
Norwalk 10
Hebei 9
Jiaxing 9
Lachine 9
Coventry 8
Kiev 8
Yuseong-gu 8
Canazei 7
Grafing 7
Cagliari 6
Chengdu 6
Codroipo 6
Frederick 6
Hefei 6
London 6
Philadelphia 6
Phoenix 6
Rome 6
Induno Olona 5
Merate 5
Montreal 5
Ningbo 5
Pavia 5
Taizhou 5
Takasago 5
Zagreb 5
Boston 4
Brno 4
Cairo 4
Carate Brianza 4
Cislago 4
Duncan 4
Falkenstein 4
Fuzhou 4
Laurel 4
Leawood 4
Paris 4
Perugia 4
Tacoma 4
Tokyo 4
Wuhan 4
Absecon 3
Anyang-si 3
Totale 6.541
Nome #
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 303
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 284
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 268
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 241
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 226
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 219
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 217
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 215
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 208
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 208
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 204
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 203
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 198
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 191
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 191
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 186
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 182
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 182
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 173
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 173
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 157
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 156
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 155
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 154
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 152
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 141
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 141
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 139
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 136
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 136
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 135
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 135
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 134
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 133
Multimodal experimental approach to the study of human neurological diseases 133
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 133
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 132
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 130
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 129
Genetic factors influencing the development of vincristine-induced neurotoxicity 129
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 127
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 126
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 126
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 125
Pharmacokinetics of IVIg in Wistar rats 116
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 114
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 112
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 104
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 103
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 101
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 101
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 101
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 100
In vitro neurotoxicity of new promising metal-based anticancer complexes 98
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 96
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 96
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 95
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 94
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 93
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 84
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 81
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 72
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 68
Blood NfL as a potential axonal damage marker in different CIPN rat models. 67
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 60
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 59
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 50
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 36
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 36
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 35
Totale 9.738
Categoria #
all - tutte 33.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020461 0 0 0 0 0 0 0 93 97 155 96 20
2020/20212.104 44 49 215 185 149 216 253 252 189 148 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20251.432 139 363 248 115 236 92 189 50 0 0 0 0
Totale 9.738